Amylase is a digestive enzyme that breaks down starch into smaller sugars your body can absorb. It’s produced mainly by your salivary glands and pancreas, and it plays a central role in how you digest carbohydrates like bread, pasta, rice, and potatoes. Amylase also shows up in blood tests as a marker for pancreatic health, with normal levels typically falling between 30 and 140 units per liter (U/L), depending on the lab.
How Amylase Breaks Down Starch
Starch is a long chain of glucose molecules linked together. Amylase works by cutting the bonds between those glucose units, chopping the chain into progressively smaller pieces. The main end products are maltose (a two-glucose sugar) and shorter starch fragments called dextrins. Another enzyme, maltase, then splits maltose into individual glucose molecules that pass through the intestinal wall and into your bloodstream.
This process starts the moment you begin chewing. That’s why a piece of bread tastes slightly sweet if you chew it long enough: salivary amylase is already converting starch to sugar in your mouth.
Salivary vs. Pancreatic Amylase
Your body produces amylase in two main locations, and each version handles a different stage of digestion.
Salivary amylase is released by glands in your mouth and gets to work as soon as food enters. It continues breaking down starch as the food travels down your esophagus, but it’s deactivated by stomach acid once it reaches your stomach. Beyond digestion, salivary amylase also influences how you perceive the texture and taste of starchy foods, and it may even trigger early metabolic signals that help your body prepare for incoming glucose.
Pancreatic amylase picks up where salivary amylase left off. The pancreas secretes it into the small intestine, where the bulk of starch digestion happens. By this stage, partially broken-down starch fragments are cleaved into maltose and other small sugars ready for final absorption. Smaller amounts of amylase are also produced by the liver, fallopian tubes, and even muscle tissue, though these contribute far less under normal conditions.
What Amylase Blood Tests Measure
A serum amylase test measures the level of amylase circulating in your blood. Most labs report a normal range somewhere around 30 to 140 U/L, though exact cutoffs vary between laboratories and testing methods. Doctors typically order the test when they suspect a problem with the pancreas, particularly acute pancreatitis.
There’s also a urine amylase test. The key difference is timing: blood amylase spikes quickly and drops back down within a day or two, while urine amylase can stay elevated for several days. That makes the urine test useful when symptoms have been going on for a while and the blood spike may have already passed.
What High Amylase Levels Mean
Elevated amylase, called hyperamylasemia, is most often evaluated in the context of acute pancreatitis. The diagnostic threshold is fairly specific: when amylase rises to three or more times the upper limit of normal and the patient has severe upper abdominal pain, a diagnosis of acute pancreatitis can be made without imaging. If levels are elevated but below that three-times threshold, a CT scan is usually needed to confirm the diagnosis.
One important nuance: the amylase level tells you something is wrong, but not how bad it is. It doesn’t predict the severity of a pancreatitis episode or point to a specific cause. It’s also not the most precise test available. Lipase, another pancreatic enzyme, is more sensitive for detecting acute pancreatitis than amylase is. Ordering both tests together doesn’t meaningfully improve diagnostic accuracy over lipase alone, which is why many hospitals now favor lipase as the primary test.
If amylase stays elevated for more than a week after an initial episode of acute pancreatitis, that prolonged elevation may signal a higher risk of recurrence.
What Low Amylase Levels Mean
Low amylase gets less attention than high amylase, but it carries its own clinical significance. When the pancreas has been damaged over a long period, as in chronic pancreatitis, the tissue that produces amylase is gradually destroyed. The result is persistently low blood amylase rather than the dramatic spikes seen in acute episodes.
Research shows that very low amylase levels are highly specific for chronic pancreatitis. In one study, amylase below 17.3 U/L had 94% specificity for the diagnosis, meaning very few people without chronic pancreatitis had levels that low. The tradeoff is sensitivity: only about 59% of people with chronic pancreatitis actually showed levels that low, so a normal reading doesn’t rule it out. Advanced chronic pancreatitis with calcification tends to produce even lower amylase levels than earlier stages of the disease.
Low amylase has also been associated with cystic fibrosis (which damages the pancreas over time), diabetes, metabolic syndrome, and high triglyceride levels. The common thread is pancreatic damage or metabolic disruption that reduces the organ’s ability to secrete enzymes normally.
Why Amylase Levels Fluctuate
Several factors can shift amylase levels independent of pancreatic disease. Because amylase is produced by multiple tissues, conditions affecting the salivary glands, liver, or reproductive organs can all raise blood levels and complicate interpretation. Salivary gland inflammation, for instance, can push amylase up without any pancreatic involvement.
Metabolic state matters too. Blood amylase responds to hormones and substances that affect how your liver handles carbohydrates. As a general pattern, states of increased carbohydrate use in the body tend to lower circulating amylase levels, and these shifts have nothing to do with pancreatic function. This is one reason doctors interpret amylase results in the context of symptoms and other tests rather than relying on a single number.